Tpl2 Kinase Inhibitor(hydrochloride)
RAS/RAS-RAF-IN-1
Tovetumab
Mavrilimumab
Panitumumab(anti-EGFR)
FLT3-IN-16
cFMS Receptor Inhibitor IV
BPI-9016M
RORγt inverse agonist 23
HS-276
SNIPER(ABL)-020
Gemnelatinib
DDR1-IN-5
PDGFRα kinase inhibitor 1
PF-6683324
Tivozanib hydrochloride hydrate
YH-306
CSF1R-IN-2
2′-Deoxy-β-L-uridine
Bz-rC Phosphoramidite
2'-O-MOE-5-Me-C(Bz)
DMTr-LNA-5MeU-3-CED-phosphoramidite
2'-O,4'-C-Methylenecytidine
2'-O-MOE-U
CDK9-IN-10
USP5-IN-1
Fludarabine triphosphate trisodium
N2-Acetylguanine
(S)-LY3177833 hydrate
Indimitecan
2'-O-Methyl-5-methyluridine
JH-XVI-178
L-Leucine-d2
Aldometanib
MOMIPP
INY-03-041
Boc-L-cyclobutylglycine
Phospho-Glycogen Synthase Peptide-2(substrate)TFA
mTOR inhibitor-1
TD52 dihydrochloride
24-Methylenecycloartanyl ferulate
(R)-PS210
L-Azatyrosine
Vidarabine phosphate
2',3'-Dideoxy-5-iodocytidine
CRS3123 dihydrochloride
Pirimiphos-methyl-d6
Kansuinine B
5-Nitrobarbituric acid
Antituberculosis agent-5
Melarsomine dihydrochloride
Bruceine B
GP(33-41)TFA
LpxC-IN-10
Tetradehydropodophyllotoxin
ROCK1-IN-1
AZ13705339 hemihydrate
2-Methoxyhydroquinone
Mps1-IN-3 hydrochloride
IZCZ-3
